200 related articles for article (PubMed ID: 30445560)
1. Association of prolactin receptor (PRLR) variants with prolactinomas.
Gorvin CM; Newey PJ; Rogers A; Stokes V; Neville MJ; Lines KE; Ntali G; Lees P; Morrison PJ; Singhellakis PN; Malandrinou FC; Karavitaki N; Grossman AB; Karpe F; Thakker RV
Hum Mol Genet; 2019 Mar; 28(6):1023-1037. PubMed ID: 30445560
[TBL] [Abstract][Full Text] [Related]
2. Germline Prolactin Receptor Mutation Is Not a Major Cause of Sporadic Prolactinoma in Humans.
Bernard V; Bouilly J; Beau I; Broutin I; Chanson P; Young J; Binart N
Neuroendocrinology; 2016; 103(6):738-45. PubMed ID: 26641246
[TBL] [Abstract][Full Text] [Related]
3. Identification of prolactin receptor variants with diverse effects on receptor signalling.
Gorvin CM; Newey PJ; Thakker RV
J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36445946
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
Xiao Z; Yang X; Zhang K; Liu Z; Shao Z; Song C; Wang X; Li Z
Int J Med Sci; 2020; 17(18):3174-3189. PubMed ID: 33173437
[TBL] [Abstract][Full Text] [Related]
5. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
6. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
[TBL] [Abstract][Full Text] [Related]
7. Impact of heat stress on prolactin-mediated ovarian JAK-STAT signaling in postpubertal gilts.
Roach CM; Bidne KL; Romoser MR; Ross JW; Baumgard LH; Keating AF
J Anim Sci; 2022 Jul; 100(7):. PubMed ID: 35772766
[TBL] [Abstract][Full Text] [Related]
8. Threonine 391 phosphorylation of the human prolactin receptor mediates a novel interaction with 14-3-3 proteins.
Olayioye MA; Guthridge MA; Stomski FC; Lopez AF; Visvader JE; Lindeman GJ
J Biol Chem; 2003 Aug; 278(35):32929-35. PubMed ID: 12819209
[TBL] [Abstract][Full Text] [Related]
9. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
Langenheim JF; Tan D; Walker AM; Chen WY
Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515
[TBL] [Abstract][Full Text] [Related]
10. Participation of Akt, menin, and p21 in pregnancy-induced beta-cell proliferation.
Hughes E; Huang C
Endocrinology; 2011 Mar; 152(3):847-55. PubMed ID: 21239436
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the novel duplicated PRLR gene at the late-feathering K locus in Lohmann chickens.
Bu G; Huang G; Fu H; Li J; Huang S; Wang Y
J Mol Endocrinol; 2013 Oct; 51(2):261-76. PubMed ID: 23940279
[TBL] [Abstract][Full Text] [Related]
12. Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.
Chang WP; Ye Y; Clevenger CV
Mol Cell Biol; 1998 Feb; 18(2):896-905. PubMed ID: 9447986
[TBL] [Abstract][Full Text] [Related]
13. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways.
Um M; Lodish HF
J Biol Chem; 2006 Mar; 281(9):5648-56. PubMed ID: 16407271
[TBL] [Abstract][Full Text] [Related]
14. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.
Schuff KG; Hentges ST; Kelly MA; Binart N; Kelly PA; Iuvone PM; Asa SL; Low MJ
J Clin Invest; 2002 Oct; 110(7):973-81. PubMed ID: 12370275
[TBL] [Abstract][Full Text] [Related]
15. Is prolactin receptor signaling a target in dopamine-resistant prolactinomas?
Ferraris J
Front Endocrinol (Lausanne); 2022; 13():1057749. PubMed ID: 36714572
[TBL] [Abstract][Full Text] [Related]
16. Pituitary prolactin-secreting tumor formation: recent developments.
Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
[TBL] [Abstract][Full Text] [Related]
17. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
Ali S; Ali S
J Biol Chem; 1998 Mar; 273(13):7709-16. PubMed ID: 9516478
[TBL] [Abstract][Full Text] [Related]
18. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
Bogorad RL; Courtillot C; Mestayer C; Bernichtein S; Harutyunyan L; Jomain JB; Bachelot A; Kuttenn F; Kelly PA; Goffin V; Touraine P;
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14533-8. PubMed ID: 18779591
[TBL] [Abstract][Full Text] [Related]
19. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomic S; Chughtai N; Ali S
Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
[TBL] [Abstract][Full Text] [Related]
20. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
Kavarthapu R; Tsai Morris CH; Dufau ML
Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
